CN114456358A - Medical anti-adhesion absorbable flexible polyester material, and preparation method and application thereof - Google Patents
Medical anti-adhesion absorbable flexible polyester material, and preparation method and application thereof Download PDFInfo
- Publication number
- CN114456358A CN114456358A CN202210090115.9A CN202210090115A CN114456358A CN 114456358 A CN114456358 A CN 114456358A CN 202210090115 A CN202210090115 A CN 202210090115A CN 114456358 A CN114456358 A CN 114456358A
- Authority
- CN
- China
- Prior art keywords
- adhesion
- polyester
- medical anti
- preparation
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000728 polyester Polymers 0.000 title claims abstract description 94
- 239000000463 material Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims description 22
- 239000000835 fiber Substances 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 6
- 150000002009 diols Chemical class 0.000 claims description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 42
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 37
- 239000002904 solvent Substances 0.000 claims description 22
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 19
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 19
- 239000000178 monomer Substances 0.000 claims description 17
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 17
- 239000003054 catalyst Substances 0.000 claims description 15
- 239000003999 initiator Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 11
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 11
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 11
- LCPNYLRZLNERIG-ZETCQYMHSA-N (2S)-6-amino-2-[2-(oxomethylidene)hydrazinyl]hexanoyl isocyanate Chemical compound NCCCC[C@H](NN=C=O)C(=O)N=C=O LCPNYLRZLNERIG-ZETCQYMHSA-N 0.000 claims description 10
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 9
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 claims description 9
- 239000012975 dibutyltin dilaurate Substances 0.000 claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 150000004985 diamines Chemical class 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- CDMDQYCEEKCBGR-UHFFFAOYSA-N 1,4-diisocyanatocyclohexane Chemical compound O=C=NC1CCC(N=C=O)CC1 CDMDQYCEEKCBGR-UHFFFAOYSA-N 0.000 claims description 5
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 4
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 3
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 3
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 claims description 3
- 125000003916 ethylene diamine group Chemical group 0.000 claims description 3
- 229940113116 polyethylene glycol 1000 Drugs 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 235000011150 stannous chloride Nutrition 0.000 claims description 3
- 239000001119 stannous chloride Substances 0.000 claims description 3
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 claims description 2
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 claims description 2
- QGDIJZMKEQCRBX-UHFFFAOYSA-N zinc;ethene Chemical compound [Zn+2].[CH-]=C.[CH-]=C QGDIJZMKEQCRBX-UHFFFAOYSA-N 0.000 claims description 2
- 125000004427 diamine group Chemical group 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 abstract description 25
- 230000015556 catabolic process Effects 0.000 abstract description 21
- 239000000126 substance Substances 0.000 abstract description 8
- 230000009477 glass transition Effects 0.000 abstract description 7
- 125000003277 amino group Chemical group 0.000 abstract description 6
- 229920000747 poly(lactic acid) Polymers 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000002378 acidificating effect Effects 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 239000004626 polylactic acid Substances 0.000 abstract description 5
- 229920000954 Polyglycolide Polymers 0.000 abstract description 4
- 239000004633 polyglycolic acid Substances 0.000 abstract description 4
- 238000001727 in vivo Methods 0.000 abstract description 2
- 238000002955 isolation Methods 0.000 abstract description 2
- 229920001610 polycaprolactone Polymers 0.000 abstract description 2
- 239000004632 polycaprolactone Substances 0.000 abstract description 2
- 239000002861 polymer material Substances 0.000 abstract description 2
- 230000002980 postoperative effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 238000001523 electrospinning Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/4269—Lactones
- C08G18/4277—Caprolactone and/or substituted caprolactone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/428—Lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/65—Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
- C08G18/66—Compounds of groups C08G18/42, C08G18/48, or C08G18/52
- C08G18/6633—Compounds of group C08G18/42
- C08G18/6637—Compounds of group C08G18/42 with compounds of group C08G18/32 or polyamines of C08G18/38
- C08G18/6648—Compounds of group C08G18/42 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3225 or C08G18/3271 and/or polyamines of C08G18/38
- C08G18/6651—Compounds of group C08G18/42 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3225 or C08G18/3271 and/or polyamines of C08G18/38 with compounds of group C08G18/3225 or polyamines of C08G18/38
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
- D01F6/70—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyurethanes
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4326—Condensation or reaction polymers
- D04H1/4358—Polyurethanes
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Textile Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
本发明提供一种医用防粘连用可吸收柔性聚酯材料及其应用,属于医用高分子材料领域。本发明中的材料为端氨基聚酯,其重均分子量为40000~200000,玻璃化转变温度在34℃~39℃,使用时将端氨基聚酯制成纤维膜,所述纤维膜的厚度为0.06mm~0.14mm,主要用于术后防粘连隔离材料。与现有技术相比,本发明从分子结构中引入聚己内酯和聚羟基乙酸结构,增加其柔顺性其纤维膜断裂伸长率达600%以上;在聚乳酸分子结构中引入氨基,由于本发明的材料在体内降解过程中会产生酸性物质,同时也会产生氨基碱性基团,氨基的碱性可以平衡酸性,使周围的降解环境维持一定范围内,使降解速度平稳,本发明材料具有优异的柔顺性、适宜的降解时间以及减少炎症的发生的优点。The invention provides an absorbable flexible polyester material for medical anti-adhesion and an application thereof, belonging to the field of medical polymer materials. The material in the present invention is amino-terminated polyester with a weight average molecular weight of 40,000-200,000 and a glass transition temperature of 34°C to 39°C. When used, the amino-terminated polyester is made into a fiber film, and the thickness of the fiber film is 0.06mm~0.14mm, mainly used for postoperative anti-adhesion isolation material. Compared with the prior art, the present invention introduces polycaprolactone and polyglycolic acid structure from the molecular structure, increases its flexibility, and the elongation at break of the fiber film reaches more than 600%; the amino group is introduced into the polylactic acid molecular structure, because The material of the present invention will produce acidic substances in the process of in vivo degradation, and will also produce amino basic groups. The basicity of the amino group can balance the acidity, maintain the surrounding degradation environment within a certain range, and make the degradation speed stable. The material of the present invention It has the advantages of excellent flexibility, suitable degradation time and reduced inflammation.
Description
技术领域technical field
本发明属于医用高分子材料领域,具体涉及一种医用防粘连用可吸收柔性聚酯材料、制备方法及其应用。The invention belongs to the field of medical polymer materials, and in particular relates to an absorbable flexible polyester material for medical anti-adhesion, a preparation method and an application thereof.
背景技术Background technique
粘连是外科手术中一种常见的并发症,给患者的生活带来了极大的痛苦。目前治疗粘连的主要方法是采用物理隔离,即在手术创面与其周围正常组织之间放入一个固体材料,设置一个物理屏障,从而在组织愈合的过程中起到隔离的作用,达到防粘连效果,有效的降低不良粘连的发生。常用材料有很多种,如透明质酸钠、壳聚糖、聚乙二醇、聚乳酸、聚乙醇酸等,由于聚乳酸具有良好的生物降解性、组织相容性和优良的力学性能等,目前市场常用材料之一,但是由于机械强度高,柔韧性有限,其降解可控性也较差,在降解过程中会产生酸性物质,导致机体炎症,影响组织的再生和康复,其临床使用效果也并不理想。国际专利W02006/100895公开了以丙交酯和己内酯共聚物为组成的医用膜,其具有很好的柔性和强度,但是材料本身的降解速率较慢,完全吸收需要6个月,有可能影响伤口愈合及组织修复功能。中国专利CN1305928C公开了乳酸与聚乙二醇共聚得到乳酸/聚乙二醇共聚物;中国专利CN103055354 B公开了丙交酯、乙交酯与聚乙二醇共聚得到聚乙二醇-聚丙交酯乙交酯嵌段共聚物。虽然两项专利将聚乙醇酸及聚乙二醇的引入可以加快聚乳酸的体内降解速率,但是在降解过程中产生酸性物质,影响周围环境pH值发生变化,影响隔膜降解速度,同时易引起炎症发生,从而限制了其在临床医用领域的广阔应用。Adhesion is a common complication in surgery, which brings great pain to patients' lives. At present, the main method of treating adhesion is to use physical isolation, that is, a solid material is placed between the surgical wound and the surrounding normal tissue to set up a physical barrier, so as to isolate the tissue during the healing process and achieve the anti-adhesion effect. Effectively reduce the occurrence of bad adhesion. There are many kinds of commonly used materials, such as sodium hyaluronate, chitosan, polyethylene glycol, polylactic acid, polyglycolic acid, etc. Because polylactic acid has good biodegradability, histocompatibility and excellent mechanical properties, etc. One of the commonly used materials in the market at present, but due to high mechanical strength and limited flexibility, its degradation controllability is also poor. During the degradation process, acidic substances will be produced, which will cause inflammation in the body and affect tissue regeneration and recovery. Its clinical use effect Not ideal either. International patent WO2006/100895 discloses a medical film composed of lactide and caprolactone copolymer, which has good flexibility and strength, but the degradation rate of the material itself is relatively slow, and it takes 6 months for complete absorption, which may affect the film. Wound healing and tissue repair functions. Chinese patent CN1305928C discloses that lactic acid and polyethylene glycol are copolymerized to obtain lactic acid/polyethylene glycol copolymer; Chinese patent CN103055354 B discloses that lactide, glycolide and polyethylene glycol are copolymerized to obtain polyethylene glycol-polylactide Glycolide block copolymer. Although the introduction of polyglycolic acid and polyethylene glycol in the two patents can speed up the degradation rate of polylactic acid in vivo, acid substances are generated during the degradation process, which will affect the pH value of the surrounding environment and affect the degradation speed of the diaphragm, and at the same time, it is easy to cause inflammation. occur, thus limiting its broad application in the field of clinical medicine.
发明内容SUMMARY OF THE INVENTION
为了解决上述技术不足,本发明的目的是提供一种医用防粘连用可吸收柔性聚酯材料、制备方法及其应用,该材料具有优异的柔顺性、适宜的降解时间以及减少炎症的发生。In order to solve the above technical deficiencies, the purpose of the present invention is to provide an absorbable flexible polyester material for medical anti-adhesion, a preparation method and an application thereof, the material has excellent flexibility, suitable degradation time and reduces the occurrence of inflammation.
为了实现上述目的,本发明的具体技术方案为:In order to achieve the above object, the concrete technical scheme of the present invention is:
一种医用防粘连用可吸收柔性聚酯材料及其应用,该材料为端氨基聚酯,其重均分子量为40000~200000,分子式为:An absorbable flexible polyester material for medical anti-adhesion and application thereof, the material is amino-terminated polyester, its weight average molecular weight is 40000-200000, and the molecular formula is:
其中:-R-为(1)、(2)、(3)中的一种或多种,Wherein: -R- is one or more of (1), (2), (3),
-R1-为:-R 1 - is:
-R2-为:-R 2 - is:
其中w=(2~145);x=(0~576);y=(0~240);z=(0~92);Where w=(2~145); x=(0~576); y=(0~240); z=(0~92);
使用时将端氨基聚酯制成纤维膜,所述纤维膜的厚度为0.06 mm ~0.14mm。When in use, the amino-terminated polyester is made into a fiber film, and the thickness of the fiber film is 0.06 mm to 0.14 mm.
上述医用防粘连用可吸收柔性聚酯材料的制备方法,由丙交酯、乙交酯、己内酯聚合得到聚酯二醇,再通过脂肪族二异氰酸酯封端,经过二元胺扩链得到。The preparation method of the above-mentioned absorbable and flexible polyester material for medical anti-adhesion is obtained by polymerizing lactide, glycolide and caprolactone to obtain polyester diol, then capping with aliphatic diisocyanate, and obtaining chain extension through diamine. .
上述医用防粘连用可吸收柔性聚酯材料的制备方法,制备方法如下:The preparation method of the above-mentioned absorbable flexible polyester material for medical anti-adhesion, the preparation method is as follows:
a、聚合:将丙交酯:乙交酯:己内酯按质量比为(63~83):(8~28):(8~10.5)加入反应器中,然后加入引发剂和催化剂溶液,通入氮气-抽真空并反复多次,在130~180℃反应4h~48h,得到粗品聚酯二醇;a. Polymerization: add lactide:glycolide:caprolactone in the mass ratio of (63~83):(8~28):(8~10.5) into the reactor, then add initiator and catalyst solution, Pour nitrogen into vacuum and repeat for several times, and react at 130~180°C for 4h~48h to obtain crude polyester diol;
b、提纯:将步骤a中得到的粗品聚酯二醇在溶剂A中完全溶解后,缓慢滴加溶剂B,使聚酯二醇慢慢析出,最后在40℃~60℃下真空干燥12h以上。b. Purification: after the crude polyester diol obtained in step a is completely dissolved in solvent A, slowly add solvent B dropwise to slowly separate out the polyester diol, and finally vacuum dry at 40°C to 60°C for more than 12 hours .
c、封端:将步骤b中得到的聚酯二醇用5~10倍重量的N,N-二甲基甲酰胺溶解,缓慢滴加脂肪族二异氰酸酯溶液,其用量为NCO:OH为(2.1~2.2):1,加入二月桂酸二丁基锡,二月桂酸二丁基锡的量为加入聚酯二醇和脂肪族二异氰酸酯总质量的0.001wt%~0.01wt%,反应温度为60℃~85℃,反应时间4 h ~24h。c, end capping: dissolving the polyester diol obtained in step b with 5~10 times weight of N,N-dimethylformamide, slowly drip aliphatic diisocyanate solution, and its consumption is NCO:OH is ( 2.1~2.2): 1. Add dibutyltin dilaurate, the amount of dibutyltin dilaurate is 0.001wt%~0.01wt% of the total mass of polyester diol and aliphatic diisocyanate added, and the reaction temperature is 60℃~85℃ , the reaction time is 4 h to 24 h.
d、扩链:在步骤c反应后的溶液中滴加二元胺单体,其用量NH2:NCO为(1.1~1.5):1,加入溶剂B析出,然后进行真空干燥,得到端氨基聚酯。d. Chain extension: add diamine monomer dropwise to the solution after the reaction in step c, the dosage of NH 2 :NCO is (1.1~1.5): 1, add solvent B to separate out, and then vacuum dry to obtain amino-terminated polyamine. ester.
上述医用防粘连用可吸收柔性聚酯材料的制备方法,其特征在于,所述步骤b中的提纯后的聚酯二醇的重均分子量为20000~100000。The above-mentioned preparation method of an absorbable flexible polyester material for medical anti-adhesion is characterized in that the weight-average molecular weight of the purified polyester diol in the step b is 20,000-100,000.
上述医用防粘连用可吸收柔性聚酯材料的制备方法,步骤a中所用的引发剂、丙交酯、乙交酯和己内酯单体在使用前均进行干燥处理,其含水量在200ppm以下。In the preparation method of the above-mentioned absorbable flexible polyester material for medical anti-adhesion, the initiator, lactide, glycolide and caprolactone monomers used in step a are all dried before use, and their water content is below 200ppm.
上述医用防粘连用可吸收柔性聚酯材料的制备方法,步骤a中的所述引发剂为乙二醇、1,4-丁二醇,聚乙二醇400、聚乙二醇1000或聚乙二醇2000中的一种,所述引发剂的用量为丙交酯、乙交酯和己内酯的投入总量的0.07wt%~7.5wt%。In the preparation method of the above-mentioned absorbable flexible polyester material for medical anti-adhesion, the initiator in step a is ethylene glycol, 1,4-butanediol, polyethylene glycol 400, polyethylene glycol 1000 or polyethylene glycol One of the diols 2000, the dosage of the initiator is 0.07wt%~7.5wt% of the total input of lactide, glycolide and caprolactone.
上述医用防粘连用可吸收柔性聚酯材料的制备方法,步骤a中的所述催化剂溶液中的溶剂为二氯甲烷,浓度为0.1wt%~10wt%,催化剂用量为丙交酯、乙交酯和己内酯的总质量的0.00015wt%~0.001wt%,所用催化剂为异丙醇铝、二乙烯基锌、氯化亚锡或辛酸亚锡中的一种或多种。In the above preparation method of absorbable flexible polyester material for medical anti-adhesion, the solvent in the catalyst solution in step a is dichloromethane, the concentration is 0.1wt%~10wt%, and the catalyst dosage is lactide, glycolide 0.00015wt% to 0.001wt% of the total mass of caprolactone, and the catalyst used is one or more of aluminum isopropoxide, zinc divinyl, stannous chloride or stannous octoate.
上述医用防粘连用可吸收柔性聚酯材料的制备方法,步骤b中的所述溶剂A为二氯甲烷、三氯甲烷或丙酮中的一种或多种,其用量为聚酯二醇的5~15倍;溶剂B为无水甲醇、无水乙醇、正己烷、乙醚或异丙醚中一种或多种。The preparation method of the above-mentioned absorbable flexible polyester material for medical anti-adhesion, the solvent A in step b is one or more of dichloromethane, chloroform or acetone, and the amount thereof is 5% of polyester diol. ~15 times; solvent B is one or more of anhydrous methanol, anhydrous ethanol, n-hexane, diethyl ether or isopropyl ether.
上述医用防粘连用可吸收柔性聚酯材料的制备方法,所述脂肪族二异氰酸酯溶液为脂肪族二异氰酸酯/N,N-二甲基甲酰胺溶液,浓度为1wt%~10wt%,所用脂肪族二异氰酸酯为六亚甲基二异氰酸酯(HDI)、1,4-环己烷二异氰酸酯(BDI)、L-赖氨酸二异氰酸酯(LDI)其中一种或多种。The preparation method of the above-mentioned absorbable flexible polyester material for medical anti-adhesion, the aliphatic diisocyanate solution is aliphatic diisocyanate/N,N-dimethylformamide solution, the concentration is 1wt%~10wt%, and the aliphatic diisocyanate solution used is 1wt%~10wt%. The diisocyanate is one or more of hexamethylene diisocyanate (HDI), 1,4-cyclohexane diisocyanate (BDI) and L-lysine diisocyanate (LDI).
上述医用防粘连用可吸收柔性聚酯材料的制备方法,所述二元胺单体为乙二胺;所述引发剂优选聚乙二醇400;所用催化剂优选为辛酸亚锡;所用脂肪族二异氰酸酯优选六亚甲基二异氰酸酯。In the preparation method of the above-mentioned absorbable flexible polyester material for medical anti-adhesion, the diamine monomer is ethylenediamine; the initiator is preferably polyethylene glycol 400; the catalyst used is preferably stannous octoate; the aliphatic diamine used is preferably The isocyanate is preferably hexamethylene diisocyanate.
与现有技术相比,本发明从分子结构中引入聚己内酯和聚羟基乙酸结构,增加其柔顺性其纤维膜断裂伸长率达600%以上,玻璃化转变温度在34℃~39℃,接近人体温度,植入患者体内具有很好地贴服性舒适感;在聚乳酸分子结构中引入氨基,由于本发明的材料在体内降解过程中产生酸性物质,同时也会产生氨基碱性基团,氨基的碱性可以平衡酸性,使周围的降解环境的PH值呈中性,使降解速度平稳,玻璃化转变温度在34℃~39℃,接近人体温度,植入患者体内具有很好地贴服性舒适感。采用本发明公开的聚酯材料制备的防粘连纤维膜,具有优异的柔软度、顺应性,能适应贴合组织部位避免缝合固定的操作且减少刺激,降解时间在6~9周。Compared with the prior art, the present invention introduces the structure of polycaprolactone and polyglycolic acid from the molecular structure, increases its flexibility, the elongation at break of the fiber film reaches more than 600%, and the glass transition temperature is between 34°C and 39°C. , close to the human body temperature, and implanted into the patient's body has a good fit and comfort; the introduction of amino groups into the molecular structure of polylactic acid, because the material of the present invention produces acidic substances during the degradation process in the body, and also produces amino-basic radicals The alkalinity of the amino group can balance the acidity, make the pH value of the surrounding degradation environment neutral, and make the degradation speed stable. The glass transition temperature is 34℃~39℃, which is close to the human body temperature. Fit comfort. The anti-adhesion fibrous membrane prepared by using the polyester material disclosed in the present invention has excellent softness and compliance, can adapt to the operation of adhering tissue parts to avoid suture fixation and reduce irritation, and the degradation time is 6-9 weeks.
具体实施方式Detailed ways
本发明的医用防粘连用可吸收柔性聚酯材料的制备方法,由丙交酯、乙交酯、己内酯聚合得到聚酯二醇,再通过脂肪族二异氰酸酯封端,经过二元胺扩链得到。In the preparation method of the absorbable flexible polyester material for medical anti-adhesion of the present invention, the polyester diol is obtained by polymerizing lactide, glycolide and caprolactone, and then end-capped by aliphatic diisocyanate, and expanded by diamine. chain get.
具体的制备方法如下:The specific preparation method is as follows:
a、聚合:将丙交酯:乙交酯:己内酯按质量比为(63~83):(8~28):(8~10.5)加入反应器中,然后加入引发剂和催化剂溶液,通入氮气-抽真空并反复多次,在130℃~180℃反应4h~48h,得到粗品聚酯二醇;a. Polymerization: add lactide:glycolide:caprolactone in the mass ratio of (63~83):(8~28):(8~10.5) into the reactor, then add initiator and catalyst solution, Pour nitrogen into vacuum and repeat for several times, and react at 130 ℃ ~ 180 ℃ for 4 h ~ 48 h to obtain crude polyester diol;
b、提纯:将步骤a中得到的粗品聚酯二醇在溶剂A中完全溶解后,缓慢滴加溶剂B,使聚酯二醇慢慢析出,最后,在40℃~60℃下真空干燥12h以上。提纯后的聚酯二醇的重均分子量为20000~100000。b. Purification: after completely dissolving the crude polyester diol obtained in step a in solvent A, slowly add solvent B dropwise to slowly separate out the polyester diol, and finally, vacuum dry at 40℃~60℃ for 12h above. The weight-average molecular weight of the purified polyester diol is 20,000 to 100,000.
c、封端:将步骤b中得到的聚酯二醇用5~10倍重量的N,N-二甲基甲酰胺溶解,缓慢滴加脂肪族二异氰酸酯溶液,其用量为NCO:OH为(2.1~2.2):1,加入二月桂酸二丁基锡,用量为聚酯二醇和脂肪族二异氰酸酯总质量的0.001wt%~0.01wt%,反应温度为60℃~85℃,反应时间4h~24h。c, end capping: dissolving the polyester diol obtained in step b with 5~10 times weight of N,N-dimethylformamide, slowly drip aliphatic diisocyanate solution, and its consumption is NCO:OH is ( 2.1~2.2): 1. Add dibutyltin dilaurate, the dosage is 0.001wt%~0.01wt% of the total mass of polyester diol and aliphatic diisocyanate, the reaction temperature is 60℃~85℃, and the reaction time is 4h~24h.
d、扩链:在步骤c反应后的溶液中滴加二元胺单体,其用量NH2:NCO为(1.1~1.5):1,加入溶剂B析出,然后进行真空干燥,得到端氨基聚酯,该端氨基聚酯的重均分子量为40000~200000。d. Chain extension: add diamine monomer dropwise to the solution after the reaction in step c, the dosage of NH 2 :NCO is (1.1~1.5): 1, add solvent B to separate out, and then vacuum dry to obtain amino-terminated polyamine. The weight-average molecular weight of the amino-terminated polyester is 40,000-200,000.
使用时,利用静电纺丝技术,将端氨基聚酯制成防粘连聚酯纤维膜,所述防粘连聚酯纤维膜的厚度为0.06 mm ~0.14mm。When in use, the amino-terminated polyester is made into an anti-blocking polyester fiber film by using an electrospinning technology, and the thickness of the anti-blocking polyester fiber film is 0.06 mm to 0.14 mm.
步骤a中所用的引发剂、丙交酯、乙交酯和己内酯单体在使用前均进行干燥处理,其含水量在200ppm以下。The initiator, lactide, glycolide and caprolactone monomers used in step a are all dried before use, and their water content is below 200 ppm.
步骤a中的所述引发剂为乙二醇、1,4-丁二醇,聚乙二醇400、聚乙二醇1000或聚乙二醇2000中的一种,所述引发剂的用量为丙交酯、乙交酯和己内酯投入总量的0.07wt%~7.5wt%。The initiator in step a is ethylene glycol, 1,4-butanediol, one of polyethylene glycol 400, polyethylene glycol 1000 or polyethylene glycol 2000, and the consumption of the initiator is The total input of lactide, glycolide and caprolactone is 0.07wt%~7.5wt%.
步骤a中的所述催化剂溶液中的溶剂为二氯甲烷,浓度为0.1wt%~10wt%,催化剂用量为所用单体总质量的0.00015wt%~0.001wt%,所用催化剂为异丙醇铝、二乙烯基锌、氯化亚锡或辛酸亚锡中的一种或多种。The solvent in the catalyst solution in step a is dichloromethane, the concentration is 0.1wt%~10wt%, the catalyst dosage is 0.00015wt%~0.001wt% of the total mass of the monomers used, and the catalyst used is aluminum isopropoxide, One or more of divinyl zinc, stannous chloride or stannous octoate.
步骤a中的所述溶剂A为二氯甲烷、三氯甲烷或丙酮中的一种或多种,其用量为聚酯二醇的5~15倍;溶剂B为无水甲醇、无水乙醇、正己烷、乙醚或异丙醚中一种或多种。The solvent A in the step a is one or more of methylene chloride, chloroform or acetone, and its consumption is 5 to 15 times that of the polyester diol; the solvent B is anhydrous methanol, anhydrous ethanol, One or more of n-hexane, diethyl ether or isopropyl ether.
所述脂肪族二异氰酸酯溶液为脂肪族二异氰酸酯/N,N-二甲基甲酰胺溶液,浓度为1wt%~10wt%,所用脂肪族二异氰酸酯为六亚甲基二异氰酸酯(HDI)、1,4-环己烷二异氰酸酯(BDI)、L-赖氨酸二异氰酸酯(LDI)其中一种或多种。The aliphatic diisocyanate solution is an aliphatic diisocyanate/N,N-dimethylformamide solution with a concentration of 1wt% to 10wt%, and the aliphatic diisocyanate used is hexamethylene diisocyanate (HDI), 1, One or more of 4-cyclohexane diisocyanate (BDI) and L-lysine diisocyanate (LDI).
所述二元胺单体为乙二胺;所述引发剂优选聚乙二醇400;所用催化剂优选为辛酸亚锡;所用脂肪族二异氰酸酯优选六亚甲基二异氰酸酯。The diamine monomer is ethylenediamine; the initiator is preferably polyethylene glycol 400; the catalyst used is preferably stannous octoate; the aliphatic diisocyanate used is preferably hexamethylene diisocyanate.
以下实施例用于说明本发明。The following examples serve to illustrate the invention.
实施例1Example 1
将所需单体经过实验室常规干燥方法进行,控制水含量在200ppm以下。The required monomers are dried by a laboratory routine, and the water content is controlled below 200 ppm.
将丙交酯70g、己内酯10.5g、乙交酯19.5g单体加入反应器中,3%辛酸亚锡/二氯甲烷溶液0.5g,聚酯二醇(400)1.5g、通氮气-抽真空反复操作3次,在真空下封管,145℃油浴中反应24h,得到粗品聚酯二醇,Add 70g of lactide, 10.5g of caprolactone, and 19.5g of glycolide into the reactor, 0.5g of 3% stannous octoate/dichloromethane solution, 1.5g of polyester diol (400), and nitrogen- Vacuuming was repeated 3 times, the tube was sealed under vacuum, and the reaction was carried out in an oil bath at 145 °C for 24 h to obtain crude polyester diol,
用1000g二氯甲烷溶解,然后缓慢滴加无水乙醇,使聚酯二醇慢慢析出,50℃下真空干燥12h,得到聚酯二醇,分子量50000;Dissolve with 1000 g of dichloromethane, then slowly add anhydrous ethanol dropwise to slowly separate out polyester diol, vacuum dry at 50°C for 12 hours to obtain polyester diol with a molecular weight of 50,000;
另取一个四口瓶中加入800gN,N-二甲基甲酰胺,80g聚酯二醇,完全溶解后缓慢滴加浓度为1wt%的六亚甲基二异氰酸酯(HDI)/N,N-二甲基甲酰胺溶液56.52g,加入0.0008g二月桂酸二丁基锡,80℃下反应时间24h。Take another four-necked bottle and add 800g N,N-dimethylformamide and 80g polyester diol. After it is completely dissolved, slowly add hexamethylene diisocyanate (HDI)/N,N-diisocyanate with a concentration of 1wt% dropwise. 56.52 g of methylformamide solution was added, 0.0008 g of dibutyltin dilaurate was added, and the reaction time was 24 hours at 80°C.
然后加入0.32g乙二胺进行扩链,最后加入无水乙醇,真空干燥得到端氨基聚酯,其分子量为100000,玻璃化转变温度为37.5℃,总溶剂残留0.15%以下,锡含量27ppm。Then add 0.32g of ethylenediamine for chain extension, finally add absolute ethanol, and vacuum dry to obtain amino-terminated polyester with a molecular weight of 100,000, a glass transition temperature of 37.5°C, a total solvent residue below 0.15%, and a tin content of 27ppm.
利用静电纺丝技术,将端氨基聚酯的制备成防粘连聚酯纤维膜,膜厚0.120mm,断裂伸长率在658%,降解时间8~9周,该膜具有很好的柔顺性和适宜的降解时间。Using electrospinning technology, the amino-terminated polyester was prepared into an anti-adhesion polyester fiber film with a film thickness of 0.120 mm, an elongation at break of 658%, and a degradation time of 8 to 9 weeks. The film has good flexibility and flexibility. suitable degradation time.
实施例2Example 2
将所需单体经过实验室常规干燥方法进行,控制水含量在200ppm以下。The required monomers are dried by a laboratory routine, and the water content is controlled below 200 ppm.
将丙交酯63g,己内酯9g、乙交酯28g单体加入反应器中,3%辛酸亚锡/二氯甲烷溶液0.5g,聚酯二醇(2000)3.5g、通氮气-抽真空反复操作3次,在真空下封管,130℃反应4h,得到粗品聚酯二醇,Add 63 g of lactide, 9 g of caprolactone, and 28 g of glycolide monomers into the reactor, 0.5 g of 3% stannous octoate/dichloromethane solution, 3.5 g of polyester diol (2000), and nitrogen-evacuated Repeat the operation 3 times, seal the tube under vacuum, and react at 130 °C for 4 h to obtain crude polyester diol,
用1500g二氯甲烷溶解,然后缓慢滴加无水乙醇,使聚酯二醇慢慢析出,50℃下真空干燥12h,得到聚酯二醇,分子量100000;Dissolve with 1500 g of dichloromethane, then slowly add anhydrous ethanol dropwise to slowly separate out polyester diol, vacuum dry at 50°C for 12 hours to obtain polyester diol with a molecular weight of 100,000;
另取一个四口瓶中加入800gN,N-二甲基甲酰胺,80g聚酯二醇,完全溶解后缓慢滴加浓度为10wt%的L-赖氨酸二异氰酸酯(LDI)/N,N-二甲基甲酰胺溶液3.98g,加入0.0040g二月桂酸二丁基锡,65℃下反应时间24h,Take another four-necked bottle, add 800g N,N-dimethylformamide and 80g polyester diol, and slowly add L-lysine diisocyanate (LDI)/N,N- 3.98g of dimethylformamide solution, 0.0040g of dibutyltin dilaurate was added, the reaction time was 24h at 65°C,
然后加入0.159g乙二胺进行扩链,最后加入无水乙醇,真空干燥得到端氨基聚酯,其各项性能如下,其分子量为200000,玻璃化转变温度35℃,总溶剂残留0.45%,锡含量36ppm。Then add 0.159g ethylenediamine for chain extension, finally add absolute ethanol, vacuum dry to obtain amino-terminated polyester, its properties are as follows, its molecular weight is 200000, glass transition temperature is 35 ℃, total solvent residue is 0.45%, tin Content 36ppm.
利用静电纺丝技术,将端氨基聚酯的制备成防粘连聚酯纤维膜,膜厚0.050mm,断裂伸长率在612%,降解时间8~9周,该膜具有很好的柔顺性和适宜的降解时间。Using electrospinning technology, the amino-terminated polyester was prepared into an anti-adhesion polyester fiber film with a film thickness of 0.050 mm, an elongation at break of 612%, and a degradation time of 8 to 9 weeks. The film has good flexibility and flexibility. suitable degradation time.
实施例3Example 3
将所需单体经过实验室常规干燥方法进行,控制水含量在200ppm以下。The required monomers are dried by a laboratory routine, and the water content is controlled below 200 ppm.
将丙交酯83g,己内酯9g、乙交酯8 g单体加入反应器中,3%辛酸亚锡/二氯甲烷溶液0.5g,聚酯二醇(400)1.0g、通氮气-抽真空反复操作3次,在真空下封管,180℃油浴中反应48h,得到粗品聚酯二醇,Add 83 g of lactide, 9 g of caprolactone, and 8 g of glycolide into the reactor, 0.5 g of 3% stannous octoate/dichloromethane solution, 1.0 g of polyester diol (400), and nitrogen-pumping The vacuum operation was repeated 3 times, the tube was sealed under vacuum, and the reaction was carried out in an oil bath at 180 °C for 48 h to obtain crude polyester diol,
用1500g二氯甲烷溶解,然后缓慢滴加无水乙醇,使聚酯二醇慢慢析出,50℃下真空干燥12h,得到聚酯二醇,分子量50000;Dissolve with 1500 g of dichloromethane, then slowly add anhydrous ethanol dropwise to slowly separate out polyester diol, vacuum dry at 50°C for 12 hours to obtain polyester diol with a molecular weight of 50,000;
另取一个四口瓶中加入800gN,N-二甲基甲酰胺,80g聚酯二醇,完全溶解后缓慢滴加浓度为5wt%的1,4-环己烷二异氰酸酯(BDI)/N,N-二甲基甲酰胺溶液11.7g,加入0.0061g二月桂酸二丁基锡,80℃下反应时间12h,Take another four-necked bottle, add 800g N,N-dimethylformamide, 80g polyester diol, and slowly dropwise add 1,4-cyclohexanediisocyanate (BDI)/N with a concentration of 5wt% after it is completely dissolved. 11.7g of N-dimethylformamide solution, 0.0061g of dibutyltin dilaurate was added, the reaction time was 12h at 80°C,
然后加入0.27g乙二胺进行扩链,最后加入无水乙醇,真空干燥得到端氨基聚酯,其分子量为100000,玻璃化转变温度39℃,总溶剂残留0.24%,锡含量含量42ppm。Then add 0.27g ethylenediamine for chain extension, finally add absolute ethanol, vacuum dry to obtain amino-terminated polyester, its molecular weight is 100000, glass transition temperature is 39°C, total solvent residue is 0.24%, and tin content is 42ppm.
利用静电纺丝技术,将端氨基聚酯的制备成防粘连聚酯纤维膜,膜厚0.120mm,断裂伸长率在620%,降解时间7~8周,该膜具有很好的柔顺性和适宜的降解时间。Using electrospinning technology, the amino-terminated polyester was prepared into an anti-adhesion polyester fiber film with a film thickness of 0.120 mm, an elongation at break of 620%, and a degradation time of 7 to 8 weeks. The film has good flexibility and flexibility. suitable degradation time.
实施例4Example 4
将所需单体经过实验室常规干燥方法进行,控制水含量在200ppm以下。The required monomers are dried by a laboratory routine, and the water content is controlled below 200 ppm.
将丙交酯66g,己内酯8g、乙交酯26g单体加入反应器中,3%辛酸亚锡/二氯甲烷溶液0.5g,聚酯二醇(1000)3.75g、通氮气-抽真空反复操作3次,在真空下封管,130℃油浴中反应4h,得到粗品聚酯二醇,Add 66g of lactide, 8g of caprolactone, and 26g of glycolide monomers into the reactor, 0.5g of 3% stannous octoate/dichloromethane solution, 3.75g of polyester diol (1000), and nitrogen-evacuated Repeat the operation 3 times, seal the tube under vacuum, and react in an oil bath at 130 °C for 4 h to obtain crude polyester diol,
用500g二氯甲烷溶解,然后缓慢滴加无水乙醇,使聚酯二醇慢慢析出,50℃下真空干燥12h,得到聚酯二醇,分子量20000;Dissolve with 500g of dichloromethane, then slowly add anhydrous ethanol dropwise to slowly separate out polyester diol, vacuum dry at 50°C for 12h to obtain polyester diol with a molecular weight of 20,000;
另取一个四口瓶中加入400gN,N-二甲基甲酰胺,80g聚酯二醇,完全溶解后缓慢滴加浓度为10 wt%的L-赖氨酸二异氰酸酯(LDI)/N,N-二甲基甲酰胺溶液19g,加入0.0082g二月桂酸二丁基锡,65℃下反应时间24h。Take another four-necked bottle and add 400g N,N-dimethylformamide and 80g polyester diol. After it is completely dissolved, slowly add L-lysine diisocyanate (LDI)/N,N with a concentration of 10 wt% dropwise. -19g of dimethylformamide solution, 0.0082g of dibutyltin dilaurate was added, and the reaction time was 24h at 65°C.
然后加入0.76g乙二胺进行扩链,最后加入无水乙醇,真空干燥得到端氨基聚酯,其分子量为50000,玻璃化转变温度34℃,总溶剂残留0.15%,锡含量45ppm。Then add 0.76g ethylenediamine for chain extension, finally add absolute ethanol, and vacuum dry to obtain amino-terminated polyester with molecular weight of 50,000, glass transition temperature of 34°C, total solvent residue of 0.15%, and tin content of 45ppm.
利用静电纺丝技术,将端氨基聚酯的制备成防粘连聚酯纤维膜,膜厚0.080mm,断裂伸长率在650%,降解时间6周~7周,该膜具有很好的柔顺性和适宜的降解时间。Using electrospinning technology, the amino-terminated polyester was prepared into an anti-adhesion polyester fiber film with a film thickness of 0.080 mm, an elongation at break of 650%, and a degradation time of 6 to 7 weeks. The film has good flexibility. and suitable degradation time.
本发明的聚酯结构中存在酯基和氨酯基,酯基在降解过程中产生酸性物质(如乳酸、乳酸低聚物、乙醇酸、乙醇酸低聚物以及COOH的低聚物等等),氨酯基降解过程中产生胺类物质(含氨基低聚物),所述酸性物质与胺类物质和聚酯分子链两端的氨基发生中和反应。从而平衡降解产物的PH值,避免炎症和不适。There are ester groups and urethane groups in the polyester structure of the present invention, and the ester groups generate acidic substances (such as lactic acid, lactic acid oligomers, glycolic acid, glycolic acid oligomers, and oligomers of COOH, etc.) during the degradation process. , amine substances (oligomers containing amino groups) are generated during the degradation of the urethane group, and the acidic substances undergo a neutralization reaction with the amine substances and the amino groups at both ends of the polyester molecular chain. This balances the pH of the degradation products and avoids inflammation and discomfort.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和变型,这些改进和变型也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention. It should be pointed out that for those skilled in the art, without departing from the technical principles of the present invention, several improvements and modifications can also be made. These improvements and modifications It should also be regarded as the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210090115.9A CN114456358A (en) | 2022-01-26 | 2022-01-26 | Medical anti-adhesion absorbable flexible polyester material, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210090115.9A CN114456358A (en) | 2022-01-26 | 2022-01-26 | Medical anti-adhesion absorbable flexible polyester material, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114456358A true CN114456358A (en) | 2022-05-10 |
Family
ID=81411227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210090115.9A Pending CN114456358A (en) | 2022-01-26 | 2022-01-26 | Medical anti-adhesion absorbable flexible polyester material, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114456358A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060172983A1 (en) * | 2005-01-28 | 2006-08-03 | Bezwada Biomedical, Llc | Functionalized drugs and polymers derived therefrom |
WO2008017247A1 (en) * | 2006-08-02 | 2008-02-14 | Sichuan University | A biodegradable polyester containing phosphatidylcholine groups and its preparation |
CN103055354A (en) * | 2013-01-17 | 2013-04-24 | 中国科学院长春应用化学研究所 | Biodegradable medical surgery anti-adhesion membrane and preparation method thereof |
CN104788695A (en) * | 2015-05-15 | 2015-07-22 | 山东师范大学 | Preparation method of biodegradable polyurethane film material |
CN106397721A (en) * | 2016-10-10 | 2017-02-15 | 同济大学 | Preparation method of biodegradable polyurethane containing unsaturated bond |
CN115518205A (en) * | 2022-09-23 | 2022-12-27 | 重庆大学 | A kind of application of shape memory polyurethane for preparing anti-adhesion film |
-
2022
- 2022-01-26 CN CN202210090115.9A patent/CN114456358A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060172983A1 (en) * | 2005-01-28 | 2006-08-03 | Bezwada Biomedical, Llc | Functionalized drugs and polymers derived therefrom |
WO2008017247A1 (en) * | 2006-08-02 | 2008-02-14 | Sichuan University | A biodegradable polyester containing phosphatidylcholine groups and its preparation |
CN103055354A (en) * | 2013-01-17 | 2013-04-24 | 中国科学院长春应用化学研究所 | Biodegradable medical surgery anti-adhesion membrane and preparation method thereof |
CN104788695A (en) * | 2015-05-15 | 2015-07-22 | 山东师范大学 | Preparation method of biodegradable polyurethane film material |
CN106397721A (en) * | 2016-10-10 | 2017-02-15 | 同济大学 | Preparation method of biodegradable polyurethane containing unsaturated bond |
CN115518205A (en) * | 2022-09-23 | 2022-12-27 | 重庆大学 | A kind of application of shape memory polyurethane for preparing anti-adhesion film |
Non-Patent Citations (2)
Title |
---|
JORG ZOTZMANN,等: "Amorphous phase-segregated copoly(ether)esterurethane thermoset networks with oligo(propylene glycol) and oligo [(rac-lactide)-co-glycolide] segments: synthesis and characterization" * |
李兴,等: "一种基于有序硬段的可生物降解聚氨酯的制备及性能" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3739501B2 (en) | Absorbed and biologically compatible segmented copolymer and process for its production | |
US5665831A (en) | Biocompatible block copolymer | |
CN101896526B (en) | High modulus polyurethane and polyurethane/urea compositions | |
CN104788695B (en) | A kind of preparation method of biodegradable polyurethane film material | |
US6113624A (en) | Absorbable elastomeric polymer | |
US8927001B2 (en) | Bioswellable, crystalline, amphiphilic, block/graft polymers and applications thereof | |
CN106589290B (en) | A kind of high-biocompatibility Phosphorylcholine modified polyurethane material and preparation method thereof | |
CN101397361B (en) | A kind of multi-block polyurethane shape memory polymer material and preparation method thereof | |
CN103897133B (en) | Polyurethane material and preparation method thereof | |
WO2005007210A1 (en) | Degradable biocompatible block copolymer | |
CN113845643B (en) | Shape memory polyurethane material with active oxygen responsiveness and anti-adhesion dual functions | |
CN100558781C (en) | A kind of thermoplastic polyurethane elastomer containing polyether polypeptide block and its synthesis method | |
CN103992465B (en) | biodegradable terpolymer | |
CN1279077C (en) | Shape memory material based on poly(e-caprolactone), preparation and metod of application | |
CN102526810A (en) | Artificial skin alternative material and preparation method thereof | |
CN114456358A (en) | Medical anti-adhesion absorbable flexible polyester material, and preparation method and application thereof | |
CN101618045B (en) | Anti-adhesion gel containing polyhydroxyalkanoate | |
CN109851744B (en) | Degradable polyurethane biomaterial and preparation method and application thereof | |
CN107964085A (en) | A kind of multi-block polyurethane shape memory high molecule material and preparation method thereof | |
CN103495211B (en) | For the absorbent antiseize film and preparation method thereof of heart operation | |
CN114524913B (en) | A highly flexible, highly elastic, degradable and adjustable absorbable polyurethane elastomer, preparation method and application | |
US8226683B2 (en) | High strength nitrogenous caprolactone copolymers and biomedical constructs therefrom | |
CN103951950B (en) | Flexible biological degradable composite material | |
CN115558078A (en) | Degradable polyurethane and application thereof | |
TW201329106A (en) | Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |